var eventsData = [{"Ticker":"AKAM","EffectiveDate":"2017-02-07","Type":"EarningsRevenueBeat","Title":"After market close, AKAM reports 2016 Q4's earning $0.72 per share and revenue $616.124MM. This beats analyst's estimated EPS $0.68, beats estimated revenue $605.19MM.","DailyReturn":"2.02%","FiveDayReturnAfter":null,"FiveDayReturnBefore":"2.76%"},{"Ticker":"AKAM","EffectiveDate":"2016-12-22","Type":"RatingNeutral","Title":"Guggenheim initiates coverage on AKAM to Buy. Target Price is $75.","DailyReturn":"-0.73%","FiveDayReturnAfter":"-1.23%","FiveDayReturnBefore":"1.3%"},{"Ticker":"AKAM","EffectiveDate":"2016-12-14","Type":"RatingUpgrade","Title":"Oppenheimer upgrades AKAM to Outperform from Perform. Target Price is $70; previously $65.","DailyReturn":"2.84%","FiveDayReturnAfter":"5.32%","FiveDayReturnBefore":"0.32%"},{"Ticker":"AKAM","EffectiveDate":"2016-11-07","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.07%","FiveDayReturnAfter":"-0.54%","FiveDayReturnBefore":"-6.04%"},{"Ticker":"AKAM","EffectiveDate":"2016-11-07","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"1.07%","FiveDayReturnAfter":"-0.54%","FiveDayReturnBefore":"-6.04%"},{"Ticker":"AKAM","EffectiveDate":"2016-10-26","Type":"RatingUpgrade","Title":"FBR Capital upgrades AKAM to Market Perform from Underperform.","DailyReturn":"14.6%","FiveDayReturnAfter":"14.22%","FiveDayReturnBefore":"5.48%"},{"Ticker":"AKAM","EffectiveDate":"2016-10-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.39%","FiveDayReturnAfter":"16.6%","FiveDayReturnBefore":"6.85%"},{"Ticker":"AKAM","EffectiveDate":"2016-10-25","Type":"EarningsRevenueBeat","Title":"After market close, AKAM reports 2016 Q3's earning $0.68 per share and revenue $584.065MM. This beats analyst's estimated EPS $0.61, beats estimated revenue $571.92MM.","DailyReturn":"0.39%","FiveDayReturnAfter":"16.6%","FiveDayReturnBefore":"6.85%"},{"Ticker":"AKAM","EffectiveDate":"2016-10-25","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.39%","FiveDayReturnAfter":"16.6%","FiveDayReturnBefore":"6.85%"},{"Ticker":"AKAM","EffectiveDate":"2016-08-12","Type":"RatingUpgrade","Title":"Wells Fargo upgrades AKAM to Outperform from Market Perform.","DailyReturn":"1.08%","FiveDayReturnAfter":"1.81%","FiveDayReturnBefore":"3.92%"},{"Ticker":"AKAM","EffectiveDate":"2016-08-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"3.58%","FiveDayReturnAfter":"3.48%","FiveDayReturnBefore":"0.51%"},{"Ticker":"AKAM","EffectiveDate":"2016-08-10","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"3.58%","FiveDayReturnAfter":"3.48%","FiveDayReturnBefore":"0.51%"},{"Ticker":"AKAM","EffectiveDate":"2016-07-27","Type":"RatingNeutral","Title":"Pacific Crest downgrades AKAM to Sector Weight from Overweight.","DailyReturn":"-13.04%","FiveDayReturnAfter":"-15.07%","FiveDayReturnBefore":"1.1%"},{"Ticker":"AKAM","EffectiveDate":"2016-07-27","Type":"RatingNeutral","Title":"Goldman Sachs maintains AKAM to Sell. Target Price is $47; previously $43.","DailyReturn":"-13.04%","FiveDayReturnAfter":"-15.07%","FiveDayReturnBefore":"1.1%"},{"Ticker":"AKAM","EffectiveDate":"2016-07-26","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.32%","FiveDayReturnAfter":"-13.47%","FiveDayReturnBefore":"0.74%"},{"Ticker":"AKAM","EffectiveDate":"2016-07-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.32%","FiveDayReturnAfter":"-13.47%","FiveDayReturnBefore":"0.74%"},{"Ticker":"AKAM","EffectiveDate":"2016-07-26","Type":"RevenueBeat","Title":"After market close, AKAM reports 2016 Q2's earning $0.64 per share and revenue $572.135MM. This meets analyst's estimated EPS $0.64, misses estimated revenue $574.86MM.","DailyReturn":"0.32%","FiveDayReturnAfter":"-13.47%","FiveDayReturnBefore":"0.74%"},{"Ticker":"AKAM","EffectiveDate":"2016-07-21","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey initiates coverage on AKAM to Buy. Target Price is $66.","DailyReturn":"-1.08%","FiveDayReturnAfter":"-13.53%","FiveDayReturnBefore":"1.69%"},{"Ticker":"AKAM","EffectiveDate":"2016-05-11","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"-2.4%","FiveDayReturnAfter":"-1.94%","FiveDayReturnBefore":"4.04%"},{"Ticker":"AKAM","EffectiveDate":"2016-04-27","Type":"RatingNeutral","Title":"Baird maintains AKAM to Outperform. Target Price is $60; previously $62.","DailyReturn":"4.15%","FiveDayReturnAfter":"-5.36%","FiveDayReturnBefore":"2.51%"},{"Ticker":"AKAM","EffectiveDate":"2016-04-27","Type":"RatingNeutral","Title":"Craig-Hallum downgrades AKAM to Hold from Buy.","DailyReturn":"4.15%","FiveDayReturnAfter":"-5.36%","FiveDayReturnBefore":"2.51%"},{"Ticker":"AKAM","EffectiveDate":"2016-04-26","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"3.07%","FiveDayReturnAfter":"-0.29%","FiveDayReturnBefore":"-1.28%"},{"Ticker":"AKAM","EffectiveDate":"2016-04-26","Type":"EarningsRevenueBeat","Title":"After market close, AKAM reports 2016 Q1's earning $0.66 per share and revenue $567.725MM. This beats analyst's estimated EPS $0.63, beats estimated revenue $563.81MM.","DailyReturn":"3.07%","FiveDayReturnAfter":"-0.29%","FiveDayReturnBefore":"-1.28%"},{"Ticker":"AKAM","EffectiveDate":"2016-04-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"3.07%","FiveDayReturnAfter":"-0.29%","FiveDayReturnBefore":"-1.28%"},{"Ticker":"AKAM","EffectiveDate":"2016-03-24","Type":"RatingNeutral","Title":"Stifel Nicolaus initiates coverage on AKAM to Hold.","DailyReturn":"-0.5%","FiveDayReturnAfter":"0.81%","FiveDayReturnBefore":"-1.24%"},{"Ticker":"AKAM","EffectiveDate":"2016-03-24","Type":"RatingNeutral","Title":"RBC Capital initiates coverage on AKAM to Sector Perform. Target Price is $62.","DailyReturn":"-0.5%","FiveDayReturnAfter":"0.81%","FiveDayReturnBefore":"-1.24%"},{"Ticker":"AKAM","EffectiveDate":"2016-02-10","Type":"RatingNeutral","Title":"Credit Suisse assumes AKAM to Neutral. Target Price is $45.","DailyReturn":"21.2%","FiveDayReturnAfter":"30.01%","FiveDayReturnBefore":"-8.17%"},{"Ticker":"AKAM","EffectiveDate":"2016-02-10","Type":"RatingNeutral","Title":"UBS maintains AKAM to Buy. Target Price is $55; previously $65.","DailyReturn":"21.2%","FiveDayReturnAfter":"30.01%","FiveDayReturnBefore":"-8.17%"},{"Ticker":"AKAM","EffectiveDate":"2016-02-10","Type":"RatingNeutral","Title":"KeyBanc maintains AKAM to Outperform. Target Price is $71; previously $75.","DailyReturn":"21.2%","FiveDayReturnAfter":"30.01%","FiveDayReturnBefore":"-8.17%"},{"Ticker":"AKAM","EffectiveDate":"2016-02-10","Type":"RatingNeutral","Title":"Deutsche Bank maintains AKAM to Buy. Target Price is $75; previously $80.","DailyReturn":"21.2%","FiveDayReturnAfter":"30.01%","FiveDayReturnBefore":"-8.17%"},{"Ticker":"AKAM","EffectiveDate":"2016-02-10","Type":"RatingUpgrade","Title":"Craig-Hallum upgrades AKAM to Buy.","DailyReturn":"21.2%","FiveDayReturnAfter":"30.01%","FiveDayReturnBefore":"-8.17%"},{"Ticker":"AKAM","EffectiveDate":"2016-02-10","Type":"RatingUpgrade","Title":"B. Riley upgrades AKAM to Buy.","DailyReturn":"21.2%","FiveDayReturnAfter":"30.01%","FiveDayReturnBefore":"-8.17%"},{"Ticker":"AKAM","EffectiveDate":"2016-02-10","Type":"RatingNeutral","Title":"JP Morgan maintains AKAM to Neutral. Target Price is $60; previously $65.","DailyReturn":"21.2%","FiveDayReturnAfter":"30.01%","FiveDayReturnBefore":"-8.17%"},{"Ticker":"AKAM","EffectiveDate":"2016-02-10","Type":"RatingNeutral","Title":"FBR Capital maintains AKAM to Underperform. Target Price is $42; previously $49.","DailyReturn":"21.2%","FiveDayReturnAfter":"30.01%","FiveDayReturnBefore":"-8.17%"},{"Ticker":"AKAM","EffectiveDate":"2016-02-09","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-3.44%","FiveDayReturnAfter":"24.86%","FiveDayReturnBefore":"-10.02%"},{"Ticker":"AKAM","EffectiveDate":"2016-02-09","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-3.44%","FiveDayReturnAfter":"24.86%","FiveDayReturnBefore":"-10.02%"},{"Ticker":"AKAM","EffectiveDate":"2016-02-03","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"3.37%","FiveDayReturnAfter":"-8.17%","FiveDayReturnBefore":"-7.31%"},{"Ticker":"AKAM","EffectiveDate":"2016-02-03","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"3.37%","FiveDayReturnAfter":"-8.17%","FiveDayReturnBefore":"-7.31%"},{"Ticker":"AKAM","EffectiveDate":"2016-01-11","Type":"RatingNeutral","Title":"Pacific Crest maintains AKAM to Outperform. Target Price is $75; previously $86.","DailyReturn":"-5.48%","FiveDayReturnAfter":"-8.56%","FiveDayReturnBefore":"-9%"},{"Ticker":"AKAM","EffectiveDate":"2016-01-11","Type":"RatingNeutral","Title":"KeyBanc maintains AKAM to Outperform. Target Price is $75; previously $86.","DailyReturn":"-5.48%","FiveDayReturnAfter":"-8.56%","FiveDayReturnBefore":"-9%"},{"Ticker":"AKAM","EffectiveDate":"2015-12-14","Type":"RatingNeutral","Title":"Evercore ISI Group initiates coverage on AKAM to Buy. Target Price is $70.","DailyReturn":"-1.4%","FiveDayReturnAfter":"0.97%","FiveDayReturnBefore":"-8.87%"},{"Ticker":"AKAM","EffectiveDate":"2015-11-20","Type":"RatingNeutral","Title":"Goldman Sachs downgrades AKAM to Sell from Neutral. Target Price is $52; previously $62.","DailyReturn":"-3.86%","FiveDayReturnAfter":"-2.23%","FiveDayReturnBefore":"-2.05%"},{"Ticker":"AKAM","EffectiveDate":"2015-11-12","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-1.59%","FiveDayReturnAfter":"-3.59%","FiveDayReturnBefore":"-1.29%"},{"Ticker":"AKAM","EffectiveDate":"2015-11-12","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.59%","FiveDayReturnAfter":"-3.59%","FiveDayReturnBefore":"-1.29%"},{"Ticker":"AKAM","EffectiveDate":"2015-11-03","Type":"RatingNeutral","Title":"Macquarie maintains AKAM to Neutral. Target Price is $65; previously $71.","DailyReturn":"2.15%","FiveDayReturnAfter":"0.08%","FiveDayReturnBefore":"-19.88%"},{"Ticker":"AKAM","EffectiveDate":"2015-10-29","Type":"RatingNeutral","Title":"FBR Capital downgrades AKAM to Underperform.","DailyReturn":"-2.86%","FiveDayReturnAfter":"-1.1%","FiveDayReturnBefore":"-12.32%"},{"Ticker":"AKAM","EffectiveDate":"2015-10-28","Type":"RatingNeutral","Title":"Craig-Hallum downgrades AKAM to Hold from Buy.","DailyReturn":"-16.73%","FiveDayReturnAfter":"-17.99%","FiveDayReturnBefore":"4.92%"},{"Ticker":"AKAM","EffectiveDate":"2015-10-28","Type":"RatingNeutral","Title":"Canaccord Genuity downgrades AKAM to Hold. Target Price is $65.","DailyReturn":"-16.73%","FiveDayReturnAfter":"-17.99%","FiveDayReturnBefore":"4.92%"},{"Ticker":"AKAM","EffectiveDate":"2015-10-28","Type":"RatingNeutral","Title":"Pacific Crest maintains AKAM to Overweight. Target Price is $86; previously $91.","DailyReturn":"-16.73%","FiveDayReturnAfter":"-17.99%","FiveDayReturnBefore":"4.92%"},{"Ticker":"AKAM","EffectiveDate":"2015-10-28","Type":"RatingNeutral","Title":"Morgan Stanley maintains AKAM to Equal-Weight. Target Price is $70; previously $75.","DailyReturn":"-16.73%","FiveDayReturnAfter":"-17.99%","FiveDayReturnBefore":"4.92%"},{"Ticker":"AKAM","EffectiveDate":"2015-10-28","Type":"RatingNeutral","Title":"JP Morgan downgrades AKAM to Neutral from Overweight. Target Price is $65; previously $75.","DailyReturn":"-16.73%","FiveDayReturnAfter":"-17.99%","FiveDayReturnBefore":"4.92%"},{"Ticker":"AKAM","EffectiveDate":"2015-10-28","Type":"RatingNeutral","Title":"B. Riley maintains AKAM to Neutral. Target Price is $64; previously $66.","DailyReturn":"-16.73%","FiveDayReturnAfter":"-17.99%","FiveDayReturnBefore":"4.92%"},{"Ticker":"AKAM","EffectiveDate":"2015-10-28","Type":"RatingNeutral","Title":"Cowen & Co. downgrades AKAM to Market Perform from Outperform.","DailyReturn":"-16.73%","FiveDayReturnAfter":"-17.99%","FiveDayReturnBefore":"4.92%"},{"Ticker":"AKAM","EffectiveDate":"2015-10-27","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.23%","FiveDayReturnAfter":"-19.88%","FiveDayReturnBefore":"6.79%"},{"Ticker":"AKAM","EffectiveDate":"2015-10-27","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.23%","FiveDayReturnAfter":"-19.88%","FiveDayReturnBefore":"6.79%"},{"Ticker":"AKAM","EffectiveDate":"2015-08-31","Type":"RatingNeutral","Title":"Deutsche Bank maintains AKAM to Buy. Target Price is $80; previously $77.","DailyReturn":"-0.82%","FiveDayReturnAfter":"0.94%","FiveDayReturnBefore":"5.51%"},{"Ticker":"AKAM","EffectiveDate":"2015-08-28","Type":"RatingUpgrade","Title":"JMP Securities upgrades AKAM to Market Outperform from Market Perform. Target Price is $85.","DailyReturn":"1.98%","FiveDayReturnAfter":"3.84%","FiveDayReturnBefore":"1.02%"},{"Ticker":"AKAM","EffectiveDate":"2015-08-20","Type":"RatingNeutral","Title":"Pacific Crest assumes AKAM to Overweight. Target Price is $91.","DailyReturn":"-4.48%","FiveDayReturnAfter":"-6.92%","FiveDayReturnBefore":"-1.17%"},{"Ticker":"AKAM","EffectiveDate":"2015-07-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"2.82%","FiveDayReturnAfter":"5.59%","FiveDayReturnBefore":"-2.55%"},{"Ticker":"AKAM","EffectiveDate":"2015-07-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2.82%","FiveDayReturnAfter":"5.59%","FiveDayReturnBefore":"-2.55%"},{"Ticker":"AKAM","EffectiveDate":"2015-07-21","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.26%","FiveDayReturnAfter":"-2.55%","FiveDayReturnBefore":"2.49%"},{"Ticker":"AKAM","EffectiveDate":"2015-07-21","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-1.26%","FiveDayReturnAfter":"-2.55%","FiveDayReturnBefore":"2.49%"},{"Ticker":"AKAM","EffectiveDate":"2015-07-09","Type":"RatingNeutral","Title":"Deutsche Bank maintains AKAM to Buy. Target Price is $77; previously $79.","DailyReturn":"0.63%","FiveDayReturnAfter":"4.54%","FiveDayReturnBefore":"-1.38%"},{"Ticker":"AKAM","EffectiveDate":"2015-06-09","Type":"RatingNeutral","Title":"Macquarie initiates coverage on AKAM to Outperform. Target Price is $75; previously $77.","DailyReturn":"-2.65%","FiveDayReturnAfter":"-3.24%","FiveDayReturnBefore":"-0.45%"},{"Ticker":"AKAM","EffectiveDate":"2015-05-19","Type":"RatingNeutral","Title":"UBS maintains AKAM to Buy. Target Price is $88; previously $79.","DailyReturn":"-0.82%","FiveDayReturnAfter":"-1.3%","FiveDayReturnBefore":"2.38%"},{"Ticker":"AKAM","EffectiveDate":"2015-05-19","Type":"RatingNeutral","Title":"Oppenheimer downgrades AKAM to Perform from Outperform.","DailyReturn":"-0.82%","FiveDayReturnAfter":"-1.3%","FiveDayReturnBefore":"2.38%"},{"Ticker":"AKAM","EffectiveDate":"2015-05-13","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.19%","FiveDayReturnAfter":"1.73%","FiveDayReturnBefore":"0.8%"},{"Ticker":"AKAM","EffectiveDate":"2015-05-13","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.19%","FiveDayReturnAfter":"1.73%","FiveDayReturnBefore":"0.8%"},{"Ticker":"AKAM","EffectiveDate":"2015-05-13","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"0.19%","FiveDayReturnAfter":"1.73%","FiveDayReturnBefore":"0.8%"},{"Ticker":"AKAM","EffectiveDate":"2015-04-29","Type":"RatingNeutral","Title":"JP Morgan maintains AKAM to Overweight. Target Price is $75; previously $73.","DailyReturn":"-1.23%","FiveDayReturnAfter":"-0.93%","FiveDayReturnBefore":"1.01%"},{"Ticker":"AKAM","EffectiveDate":"2015-04-29","Type":"RatingUpgrade","Title":"Deutsche Bank upgrades AKAM to Buy from Hold.","DailyReturn":"-1.23%","FiveDayReturnAfter":"-0.93%","FiveDayReturnBefore":"1.01%"},{"Ticker":"AKAM","EffectiveDate":"2015-04-29","Type":"RatingNeutral","Title":"Canaccord Genuity maintains AKAM to Buy. Target Price is $78; previously $75.","DailyReturn":"-1.23%","FiveDayReturnAfter":"-0.93%","FiveDayReturnBefore":"1.01%"},{"Ticker":"AKAM","EffectiveDate":"2015-04-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-1.25%","FiveDayReturnAfter":"-2.55%","FiveDayReturnBefore":"4.75%"},{"Ticker":"AKAM","EffectiveDate":"2015-04-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.25%","FiveDayReturnAfter":"-2.55%","FiveDayReturnBefore":"4.75%"},{"Ticker":"AKAM","EffectiveDate":"2015-04-09","Type":"RatingNeutral","Title":"Deutsche Bank initiates coverage on AKAM to Hold. Target Price is $73.","DailyReturn":"-0.73%","FiveDayReturnAfter":"-0.62%","FiveDayReturnBefore":"1.03%"},{"Ticker":"AKAM","EffectiveDate":"2015-02-10","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"2.05%","FiveDayReturnAfter":"14.34%","FiveDayReturnBefore":"4.13%"},{"Ticker":"AKAM","EffectiveDate":"2015-02-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2.05%","FiveDayReturnAfter":"14.34%","FiveDayReturnBefore":"4.13%"},{"Ticker":"AKAM","EffectiveDate":"2015-02-04","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.28%","FiveDayReturnAfter":"3.41%","FiveDayReturnBefore":"-0.28%"},{"Ticker":"AKAM","EffectiveDate":"2015-02-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.28%","FiveDayReturnAfter":"3.41%","FiveDayReturnBefore":"-0.28%"},{"Ticker":"AKAM","EffectiveDate":"2015-01-09","Type":"RatingNeutral","Title":"B. Riley downgrades AKAM to Neutral from Buy. Target Price is $69; previously $70.","DailyReturn":"-1.28%","FiveDayReturnAfter":"-4.89%","FiveDayReturnBefore":"-2.23%"},{"Ticker":"AKAM","EffectiveDate":"2014-12-30","Type":"RatingNeutral","Title":"DA Davidson maintains AKAM to Buy. Target Price is $86; previously $72.","DailyReturn":"0.43%","FiveDayReturnAfter":"-5.01%","FiveDayReturnBefore":"0.92%"},{"Ticker":"AKAM","EffectiveDate":"2014-11-17","Type":"RatingNeutral","Title":"JMP Securities initiates coverage on AKAM to Market Perform.","DailyReturn":"-1.43%","FiveDayReturnAfter":"1.26%","FiveDayReturnBefore":"4.53%"},{"Ticker":"AKAM","EffectiveDate":"2014-10-30","Type":"RatingNeutral","Title":"Credit Suisse maintains AKAM to Neutral. Target Price is $52.5; previously $50.","DailyReturn":"6.44%","FiveDayReturnAfter":"4.87%","FiveDayReturnBefore":"4.1%"},{"Ticker":"AKAM","EffectiveDate":"2014-10-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.64%","FiveDayReturnAfter":"4.24%","FiveDayReturnBefore":"3.81%"},{"Ticker":"AKAM","EffectiveDate":"2014-10-29","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-1.64%","FiveDayReturnAfter":"4.24%","FiveDayReturnBefore":"3.81%"},{"Ticker":"AKAM","EffectiveDate":"2014-10-22","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"-1.92%","FiveDayReturnAfter":"3.81%","FiveDayReturnBefore":"-1.15%"},{"Ticker":"AKAM","EffectiveDate":"2014-10-22","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.92%","FiveDayReturnAfter":"3.81%","FiveDayReturnBefore":"-1.15%"},{"Ticker":"AKAM","EffectiveDate":"2014-09-05","Type":"RatingNeutral","Title":"UBS initiates coverage on AKAM to Buy. Target Price is $70.","DailyReturn":"1.85%","FiveDayReturnAfter":"3.09%","FiveDayReturnBefore":"-0.13%"},{"Ticker":"AKAM","EffectiveDate":"2014-08-27","Type":"RatingNeutral","Title":"Baird initiates coverage on AKAM to Outperform. Target Price is $71.","DailyReturn":"-0.09%","FiveDayReturnAfter":"-0.31%","FiveDayReturnBefore":"-0.54%"},{"Ticker":"AKAM","EffectiveDate":"2014-07-31","Type":"RatingNeutral","Title":"Credit Suisse maintains AKAM to Neutral. Target Price is $50; previously $47.5.","DailyReturn":"-2.81%","FiveDayReturnAfter":"-7.14%","FiveDayReturnBefore":"3.75%"},{"Ticker":"AKAM","EffectiveDate":"2014-07-31","Type":"RatingNeutral","Title":"JP Morgan maintains AKAM to Overweight. Target Price is $73; previously $67.5.","DailyReturn":"-2.81%","FiveDayReturnAfter":"-7.14%","FiveDayReturnBefore":"3.75%"},{"Ticker":"AKAM","EffectiveDate":"2014-07-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2.93%","FiveDayReturnAfter":"-3.69%","FiveDayReturnBefore":"0.13%"},{"Ticker":"AKAM","EffectiveDate":"2014-07-30","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"2.93%","FiveDayReturnAfter":"-3.69%","FiveDayReturnBefore":"0.13%"},{"Ticker":"AKAM","EffectiveDate":"2014-07-24","Type":"RatingUpgrade","Title":"Macquarie upgrades AKAM to Outperform from Neutral. Target Price is $70; previously $59.","DailyReturn":"2.23%","FiveDayReturnAfter":"3.75%","FiveDayReturnBefore":"-1.05%"},{"Ticker":"AKAM","EffectiveDate":"2014-05-14","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"1.42%","FiveDayReturnAfter":"-2%","FiveDayReturnBefore":"1.7%"},{"Ticker":"AKAM","EffectiveDate":"2014-05-14","Type":"RatingUpgrade","Title":"Pacific Crest upgrades AKAM to Outperform from Sector Perform. Target Price is $65.","DailyReturn":"1.42%","FiveDayReturnAfter":"-2%","FiveDayReturnBefore":"1.7%"},{"Ticker":"AKAM","EffectiveDate":"2014-05-14","Type":"RatingNeutral","Title":"B. Riley maintains AKAM to Buy. Target Price is $68.","DailyReturn":"1.42%","FiveDayReturnAfter":"-2%","FiveDayReturnBefore":"1.7%"},{"Ticker":"AKAM","EffectiveDate":"2014-05-02","Type":"RatingNeutral","Title":"Jefferies maintains AKAM to Hold. Target Price is $54; previously $52.","DailyReturn":"-2.47%","FiveDayReturnAfter":"-4.34%","FiveDayReturnBefore":"2.18%"},{"Ticker":"AKAM","EffectiveDate":"2014-05-02","Type":"RatingNeutral","Title":"JP Morgan maintains AKAM to Overweight. Target Price is $67.5; previously $63.","DailyReturn":"-2.47%","FiveDayReturnAfter":"-4.34%","FiveDayReturnBefore":"2.18%"},{"Ticker":"AKAM","EffectiveDate":"2014-05-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2.75%","FiveDayReturnAfter":"-2.3%","FiveDayReturnBefore":"-1.31%"},{"Ticker":"AKAM","EffectiveDate":"2014-05-01","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"2.75%","FiveDayReturnAfter":"-2.3%","FiveDayReturnBefore":"-1.31%"},{"Ticker":"AKAM","EffectiveDate":"2014-04-10","Type":"RatingUpgrade","Title":"B. Riley upgrades AKAM to Buy from Neutral. Target Price is $68; previously $52.","DailyReturn":"-4.16%","FiveDayReturnAfter":"-1.2%","FiveDayReturnBefore":"-5.29%"},{"Ticker":"AKAM","EffectiveDate":"2014-02-18","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"0.98%","FiveDayReturnAfter":"4.25%","FiveDayReturnBefore":"5.81%"},{"Ticker":"AKAM","EffectiveDate":"2014-02-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.98%","FiveDayReturnAfter":"4.25%","FiveDayReturnBefore":"5.81%"},{"Ticker":"AKAM","EffectiveDate":"2014-02-18","Type":"Item_2.01","Title":"Completion of Acquisition or Disposition of Assets\r\n","DailyReturn":"0.98%","FiveDayReturnAfter":"4.25%","FiveDayReturnBefore":"5.81%"},{"Ticker":"AKAM","EffectiveDate":"2014-02-13","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.96%","FiveDayReturnAfter":"3.99%","FiveDayReturnBefore":"22.08%"},{"Ticker":"AKAM","EffectiveDate":"2014-02-13","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":"0.96%","FiveDayReturnAfter":"3.99%","FiveDayReturnBefore":"22.08%"},{"Ticker":"AKAM","EffectiveDate":"2014-02-13","Type":"Item_3.02","Title":"Unregistered Sales of Equity Securities\r\n","DailyReturn":"0.96%","FiveDayReturnAfter":"3.99%","FiveDayReturnBefore":"22.08%"},{"Ticker":"AKAM","EffectiveDate":"2014-02-13","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"0.96%","FiveDayReturnAfter":"3.99%","FiveDayReturnBefore":"22.08%"},{"Ticker":"AKAM","EffectiveDate":"2014-02-13","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"0.96%","FiveDayReturnAfter":"3.99%","FiveDayReturnBefore":"22.08%"},{"Ticker":"AKAM","EffectiveDate":"2014-02-12","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.08%","FiveDayReturnAfter":"1.21%","FiveDayReturnBefore":"25.16%"},{"Ticker":"AKAM","EffectiveDate":"2014-02-12","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-1.08%","FiveDayReturnAfter":"1.21%","FiveDayReturnBefore":"25.16%"},{"Ticker":"AKAM","EffectiveDate":"2014-02-12","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-1.08%","FiveDayReturnAfter":"1.21%","FiveDayReturnBefore":"25.16%"},{"Ticker":"AKAM","EffectiveDate":"2014-02-12","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.08%","FiveDayReturnAfter":"1.21%","FiveDayReturnBefore":"25.16%"},{"Ticker":"AKAM","EffectiveDate":"2014-02-07","Type":"RatingNeutral","Title":"DA Davidson maintains AKAM to Buy. Target Price is $63; previously $62.","DailyReturn":"-0.94%","FiveDayReturnAfter":"4.32%","FiveDayReturnBefore":"16.52%"},{"Ticker":"AKAM","EffectiveDate":"2014-02-05","Type":"RatingUpgrade","Title":"Credit Suisse upgrades AKAM to Neutral from Underperform.","DailyReturn":"2%","FiveDayReturnAfter":"25.16%","FiveDayReturnBefore":"-3.92%"},{"Ticker":"AKAM","EffectiveDate":"2014-02-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2%","FiveDayReturnAfter":"25.16%","FiveDayReturnBefore":"-3.92%"},{"Ticker":"AKAM","EffectiveDate":"2014-02-05","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"2%","FiveDayReturnAfter":"25.16%","FiveDayReturnBefore":"-3.92%"},{"Ticker":"AKAM","EffectiveDate":"2014-01-31","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-1.62%","FiveDayReturnAfter":"16.52%","FiveDayReturnBefore":"-2.32%"},{"Ticker":"AKAM","EffectiveDate":"2014-01-31","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-1.62%","FiveDayReturnAfter":"16.52%","FiveDayReturnBefore":"-2.32%"},{"Ticker":"AKAM","EffectiveDate":"2013-12-02","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.36%","FiveDayReturnAfter":"0.51%","FiveDayReturnBefore":"0.6%"},{"Ticker":"AKAM","EffectiveDate":"2013-12-02","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"-1.36%","FiveDayReturnAfter":"0.51%","FiveDayReturnBefore":"0.6%"},{"Ticker":"AKAM","EffectiveDate":"2013-11-08","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.77%","FiveDayReturnAfter":"3.72%","FiveDayReturnBefore":"-0.62%"},{"Ticker":"AKAM","EffectiveDate":"2013-11-08","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"1.77%","FiveDayReturnAfter":"3.72%","FiveDayReturnBefore":"-0.62%"},{"Ticker":"AKAM","EffectiveDate":"2013-10-24","Type":"RatingNeutral","Title":"Jefferies maintains AKAM to Hold. Target Price is $44; previously $45.","DailyReturn":"-11.2%","FiveDayReturnAfter":"-12.99%","FiveDayReturnBefore":"0.11%"},{"Ticker":"AKAM","EffectiveDate":"2013-10-23","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-2.84%","FiveDayReturnAfter":"-13.66%","FiveDayReturnBefore":"3.97%"},{"Ticker":"AKAM","EffectiveDate":"2013-10-23","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-2.84%","FiveDayReturnAfter":"-13.66%","FiveDayReturnBefore":"3.97%"},{"Ticker":"AKAM","EffectiveDate":"2013-10-16","Type":"RatingUpgrade","Title":"DA Davidson upgrades AKAM to Buy from Neutral. Target Price is $62.","DailyReturn":"0.97%","FiveDayReturnAfter":"3.97%","FiveDayReturnBefore":"2.58%"},{"Ticker":"AKAM","EffectiveDate":"2013-09-27","Type":"RatingNeutral","Title":"B. Riley downgrades AKAM to Neutral from Buy. Target Price is $55.","DailyReturn":"-1.93%","FiveDayReturnAfter":"-3.09%","FiveDayReturnBefore":"0%"},{"Ticker":"AKAM","EffectiveDate":"2013-07-24","Type":"EarningsRelease","Title":"AKAM reports 2013 Q2's earning $0.46 per share and revenue $378MM. This meets analyst's estimated EPS $0.46, beats estimated revenue $374.15MM.","DailyReturn":"-0.85%","FiveDayReturnAfter":"6.17%","FiveDayReturnBefore":"-0.38%"},{"Ticker":"AKAM","EffectiveDate":"2013-07-24","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.85%","FiveDayReturnAfter":"6.17%","FiveDayReturnBefore":"-0.38%"},{"Ticker":"AKAM","EffectiveDate":"2013-07-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.85%","FiveDayReturnAfter":"6.17%","FiveDayReturnBefore":"-0.38%"},{"Ticker":"AKAM","EffectiveDate":"2013-06-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-3.07%","FiveDayReturnAfter":"0.46%","FiveDayReturnBefore":"0.09%"},{"Ticker":"AKAM","EffectiveDate":"2013-06-20","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-3.07%","FiveDayReturnAfter":"0.46%","FiveDayReturnBefore":"0.09%"},{"Ticker":"AKAM","EffectiveDate":"2013-06-03","Type":"RatingNeutral","Title":"Jefferies maintains AKAM to Hold. Target Price is $44; previously $40.","DailyReturn":"-0.45%","FiveDayReturnAfter":"-1.88%","FiveDayReturnBefore":"-0.49%"},{"Ticker":"AKAM","EffectiveDate":"2013-05-29","Type":"RatingNeutral","Title":"DA Davidson downgrades AKAM to Neutral from Buy. Target Price is $50.","DailyReturn":"-0.42%","FiveDayReturnAfter":"-4.18%","FiveDayReturnBefore":"-2.81%"},{"Ticker":"AKAM","EffectiveDate":"2013-05-15","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"2.4%","FiveDayReturnAfter":"0.8%","FiveDayReturnBefore":"3.8%"},{"Ticker":"AKAM","EffectiveDate":"2013-05-15","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2.4%","FiveDayReturnAfter":"0.8%","FiveDayReturnBefore":"3.8%"},{"Ticker":"AKAM","EffectiveDate":"2013-05-15","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"2.4%","FiveDayReturnAfter":"0.8%","FiveDayReturnBefore":"3.8%"},{"Ticker":"AKAM","EffectiveDate":"2013-04-30","Type":"RatingNeutral","Title":"MKM Partners initiates coverage on AKAM to Buy. Target Price is $60.","DailyReturn":"2.04%","FiveDayReturnAfter":"4.6%","FiveDayReturnBefore":"22.73%"},{"Ticker":"AKAM","EffectiveDate":"2013-04-25","Type":"RatingUpgrade","Title":"JP Morgan upgrades AKAM to Overweight from Neutral. Target Price is $52; previously $42.","DailyReturn":"17.7%","FiveDayReturnAfter":"18.99%","FiveDayReturnBefore":"5.43%"},{"Ticker":"AKAM","EffectiveDate":"2013-04-24","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.74%","FiveDayReturnAfter":"21.34%","FiveDayReturnBefore":"1.93%"},{"Ticker":"AKAM","EffectiveDate":"2013-04-24","Type":"EarningsRevenueBeat","Title":"After market close, AKAM reports 2013 Q1's earning $0.51 per share and revenue $368MM. This beats analyst's estimated EPS $0.47, beats estimated revenue $357.51MM.","DailyReturn":"1.74%","FiveDayReturnAfter":"21.34%","FiveDayReturnBefore":"1.93%"},{"Ticker":"AKAM","EffectiveDate":"2013-04-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.74%","FiveDayReturnAfter":"21.34%","FiveDayReturnBefore":"1.93%"},{"Ticker":"AKAM","EffectiveDate":"2013-04-12","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-1.06%","FiveDayReturnAfter":"-5.89%","FiveDayReturnBefore":"4.95%"},{"Ticker":"AKAM","EffectiveDate":"2013-03-20","Type":"RatingNeutral","Title":"FBN Securities initiates coverage on AKAM to Outperform. Target Price is $45.","DailyReturn":"2.24%","FiveDayReturnAfter":"1.17%","FiveDayReturnBefore":"-0.28%"},{"Ticker":"AKAM","EffectiveDate":"2013-03-15","Type":"RatingNeutral","Title":"Maxim Group initiates coverage on AKAM to Buy. Target Price is $44.","DailyReturn":"0.08%","FiveDayReturnAfter":"1%","FiveDayReturnBefore":"-7.28%"},{"Ticker":"AKAM","EffectiveDate":"2013-03-01","Type":"RatingNeutral","Title":"Oppenheimer maintains AKAM to Outperform. Target Price is $45; previously $48.","DailyReturn":"-0.83%","FiveDayReturnAfter":"0.86%","FiveDayReturnBefore":"-0.29%"},{"Ticker":"AKAM","EffectiveDate":"2013-02-25","Type":"RatingUpgrade","Title":"Macquarie upgrades AKAM to Outperform from Neutral. Target Price is $42; previously $41.5.","DailyReturn":"0.11%","FiveDayReturnAfter":"1.04%","FiveDayReturnBefore":"-4.31%"},{"Ticker":"AKAM","EffectiveDate":"2013-02-07","Type":"RatingNeutral","Title":"Janney Capital downgrades AKAM to Neutral from Buy.","DailyReturn":"-15.19%","FiveDayReturnAfter":"-10.83%","FiveDayReturnBefore":"2.87%"},{"Ticker":"AKAM","EffectiveDate":"2013-02-07","Type":"RatingNeutral","Title":"Jefferies downgrades AKAM to Hold from Buy. Target Price is $40; previously $44.","DailyReturn":"-15.19%","FiveDayReturnAfter":"-10.83%","FiveDayReturnBefore":"2.87%"},{"Ticker":"AKAM","EffectiveDate":"2013-02-06","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.29%","FiveDayReturnAfter":"-11.09%","FiveDayReturnBefore":"2.14%"},{"Ticker":"AKAM","EffectiveDate":"2013-02-06","Type":"EarningsBeatRevenueMiss","Title":"After market close, AKAM reports 2012 Q4's earning $0.54 per share and revenue $378MM. This beats analyst's estimated EPS $0.5, misses estimated revenue $381.07MM.","DailyReturn":"1.29%","FiveDayReturnAfter":"-11.09%","FiveDayReturnBefore":"2.14%"},{"Ticker":"AKAM","EffectiveDate":"2013-02-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.29%","FiveDayReturnAfter":"-11.09%","FiveDayReturnBefore":"2.14%"},{"Ticker":"AKAM","EffectiveDate":"2013-01-16","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.73%","FiveDayReturnAfter":"1%","FiveDayReturnBefore":"-1.2%"},{"Ticker":"AKAM","EffectiveDate":"2012-12-12","Type":"RatingNeutral","Title":"Goldman Sachs assumes AKAM to Neutral. Target Price is $44.","DailyReturn":"0.93%","FiveDayReturnAfter":"3.32%","FiveDayReturnBefore":"9.53%"},{"Ticker":"AKAM","EffectiveDate":"2012-12-11","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"1.02%","FiveDayReturnAfter":"0.66%","FiveDayReturnBefore":"8.23%"},{"Ticker":"AKAM","EffectiveDate":"2012-11-14","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"-2.56%","FiveDayReturnAfter":"-1.89%","FiveDayReturnBefore":"-6.81%"},{"Ticker":"AKAM","EffectiveDate":"2012-11-14","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-2.56%","FiveDayReturnAfter":"-1.89%","FiveDayReturnBefore":"-6.81%"},{"Ticker":"AKAM","EffectiveDate":"2012-10-25","Type":"RatingUpgrade","Title":"Canaccord Genuity upgrades AKAM to Buy from Hold. Target Price is $45; previously $38.","DailyReturn":"6.72%","FiveDayReturnAfter":"5.83%","FiveDayReturnBefore":"-5.04%"},{"Ticker":"AKAM","EffectiveDate":"2012-10-25","Type":"RatingNeutral","Title":"Jefferies maintains AKAM to Buy. Target Price is $44; previously $43.","DailyReturn":"6.72%","FiveDayReturnAfter":"5.83%","FiveDayReturnBefore":"-5.04%"},{"Ticker":"AKAM","EffectiveDate":"2012-10-25","Type":"RatingUpgrade","Title":"Oppenheimer upgrades AKAM to Outperform from Perform. Target Price is $50.","DailyReturn":"6.72%","FiveDayReturnAfter":"5.83%","FiveDayReturnBefore":"-5.04%"},{"Ticker":"AKAM","EffectiveDate":"2012-10-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.04%","FiveDayReturnAfter":"5.54%","FiveDayReturnBefore":"-5.95%"},{"Ticker":"AKAM","EffectiveDate":"2012-10-24","Type":"EarningsRevenueBeat","Title":"After market close, AKAM reports 2012 Q3's earning $0.43 per share and revenue $345MM. This beats analyst's estimated EPS $0.41, beats estimated revenue $338.2MM.","DailyReturn":"-1.04%","FiveDayReturnAfter":"5.54%","FiveDayReturnBefore":"-5.95%"},{"Ticker":"AKAM","EffectiveDate":"2012-10-24","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-1.04%","FiveDayReturnAfter":"5.54%","FiveDayReturnBefore":"-5.95%"},{"Ticker":"AKAM","EffectiveDate":"2012-08-29","Type":"RatingNeutral","Title":"Canaccord Genuity maintains AKAM to Hold. Target Price is $37; previously $34.","DailyReturn":"0.99%","FiveDayReturnAfter":"1.06%","FiveDayReturnBefore":"-0.32%"},{"Ticker":"AKAM","EffectiveDate":"2012-07-26","Type":"RatingNeutral","Title":"Canaccord Genuity maintains AKAM to Hold. Target Price is $34; previously $32.","DailyReturn":"24.03%","FiveDayReturnAfter":"21.79%","FiveDayReturnBefore":"-5.74%"},{"Ticker":"AKAM","EffectiveDate":"2012-07-25","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.49%","FiveDayReturnAfter":"21.44%","FiveDayReturnBefore":"-6.27%"},{"Ticker":"AKAM","EffectiveDate":"2012-07-25","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.49%","FiveDayReturnAfter":"21.44%","FiveDayReturnBefore":"-6.27%"},{"Ticker":"AKAM","EffectiveDate":"2012-07-25","Type":"EarningsRevenueBeat","Title":"AKAM reports 2012 Q2's earning $0.43 per share and revenue $331MM. This beats analyst's estimated EPS $0.37, beats estimated revenue $325.74MM.","DailyReturn":"-0.49%","FiveDayReturnAfter":"21.44%","FiveDayReturnBefore":"-6.27%"},{"Ticker":"AKAM","EffectiveDate":"2012-07-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.49%","FiveDayReturnAfter":"21.44%","FiveDayReturnBefore":"-6.27%"},{"Ticker":"AKAM","EffectiveDate":"2012-07-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.02%","FiveDayReturnAfter":"-6.27%","FiveDayReturnBefore":"1.73%"},{"Ticker":"AKAM","EffectiveDate":"2012-07-18","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-1.02%","FiveDayReturnAfter":"-6.27%","FiveDayReturnBefore":"1.73%"},{"Ticker":"AKAM","EffectiveDate":"2012-05-16","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-3.37%","FiveDayReturnAfter":"-3.4%","FiveDayReturnBefore":"-6.69%"},{"Ticker":"AKAM","EffectiveDate":"2012-05-16","Type":"RatingUpgrade","Title":"Citigroup upgrades AKAM to Neutral from Sell. Target Price is $32.","DailyReturn":"-3.37%","FiveDayReturnAfter":"-3.4%","FiveDayReturnBefore":"-6.69%"},{"Ticker":"AKAM","EffectiveDate":"2012-05-16","Type":"RatingNeutral","Title":"Canaccord Genuity maintains AKAM to Hold. Target Price is $32; previously $34.","DailyReturn":"-3.37%","FiveDayReturnAfter":"-3.4%","FiveDayReturnBefore":"-6.69%"},{"Ticker":"AKAM","EffectiveDate":"2012-05-16","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"-3.37%","FiveDayReturnAfter":"-3.4%","FiveDayReturnBefore":"-6.69%"},{"Ticker":"AKAM","EffectiveDate":"2012-05-01","Type":"EarningsRelease","Title":"After market close, AKAM reports 2012 Q1's earning $0.24 per share and revenue $319.448MM..","DailyReturn":"3.12%","FiveDayReturnAfter":"-0.95%","FiveDayReturnBefore":"-15.62%"},{"Ticker":"AKAM","EffectiveDate":"2012-04-26","Type":"RatingUpgrade","Title":"Jefferies upgrades AKAM to Buy from Hold. Target Price is $42; previously $41.","DailyReturn":"-14.45%","FiveDayReturnAfter":"-12.81%","FiveDayReturnBefore":"0.88%"},{"Ticker":"AKAM","EffectiveDate":"2012-04-25","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"2.67%","FiveDayReturnAfter":"-11.58%","FiveDayReturnBefore":"0.29%"},{"Ticker":"AKAM","EffectiveDate":"2012-04-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2.67%","FiveDayReturnAfter":"-11.58%","FiveDayReturnBefore":"0.29%"},{"Ticker":"AKAM","EffectiveDate":"2012-04-25","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"2.67%","FiveDayReturnAfter":"-11.58%","FiveDayReturnBefore":"0.29%"},{"Ticker":"AKAM","EffectiveDate":"2012-04-04","Type":"RatingUpgrade","Title":"DA Davidson upgrades AKAM to Buy from Neutral. Target Price is $45; previously $40.","DailyReturn":"0.27%","FiveDayReturnAfter":"-1.1%","FiveDayReturnBefore":"-3.51%"},{"Ticker":"AKAM","EffectiveDate":"2012-03-14","Type":"RatingNeutral","Title":"Oxen Group initiates coverage on AKAM to Hold. Target Price is $44.","DailyReturn":"-2.16%","FiveDayReturnAfter":"-1.94%","FiveDayReturnBefore":"7.19%"},{"Ticker":"AKAM","EffectiveDate":"2012-02-09","Type":"RatingNeutral","Title":"PiperJaffray maintains AKAM to Neutral. Target Price is $36; previously $26.","DailyReturn":"10.51%","FiveDayReturnAfter":"9.99%","FiveDayReturnBefore":"7.31%"},{"Ticker":"AKAM","EffectiveDate":"2012-02-09","Type":"RatingNeutral","Title":"Jefferies maintains AKAM to Hold. Target Price is $41; previously $36.","DailyReturn":"10.51%","FiveDayReturnAfter":"9.99%","FiveDayReturnBefore":"7.31%"},{"Ticker":"AKAM","EffectiveDate":"2012-02-09","Type":"RatingNeutral","Title":"DA Davidson maintains AKAM to Neutral. Target Price is $40; previously $36.","DailyReturn":"10.51%","FiveDayReturnAfter":"9.99%","FiveDayReturnBefore":"7.31%"},{"Ticker":"AKAM","EffectiveDate":"2012-02-09","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains AKAM to Buy. Target Price is $43; previously $32.","DailyReturn":"10.51%","FiveDayReturnAfter":"9.99%","FiveDayReturnBefore":"7.31%"}];